Ditchcarbon
  • Customers
  1. Organizations
  2. Gulf Pharmaceutical
Public Profile
Pharmaceutical Preparation Manufacturing
AE
updated 10 days ago

Gulf Pharmaceutical

Company website

Gulf Pharmaceutical Industries, commonly known as Julphar, is a leading pharmaceutical company headquartered in the United Arab Emirates (AE). Established in 1980, Julphar has grown to become a prominent player in the Middle East and North Africa (MENA) region, focusing on the development, manufacturing, and distribution of high-quality pharmaceutical products. With a diverse portfolio that includes prescription medications, over-the-counter products, and biotechnology solutions, Julphar is renowned for its commitment to innovation and quality. The company has achieved significant milestones, including the establishment of state-of-the-art manufacturing facilities and a robust research and development programme. Julphar's dedication to excellence has positioned it as a trusted name in the pharmaceutical industry, contributing to improved healthcare outcomes across its operational regions.

DitchCarbon Score

How does Gulf Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

41

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Gulf Pharmaceutical's score of 41 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.

65%

Let us know if this data was useful to you

Gulf Pharmaceutical's reported carbon emissions

In 2023, Gulf Pharmaceutical Industries P.S.C. reported total carbon emissions of approximately 137,000 kg CO2e. This figure includes 48,000 kg CO2e from Scope 1 emissions, 38,000 kg CO2e from Scope 2 emissions, and 51,000 kg CO2e from Scope 3 emissions. Compared to 2022, the company achieved a 3% reduction in Scope 1 emissions and a 2% reduction in Scope 2 emissions, reflecting their commitment to decreasing greenhouse gas emissions through reduced diesel and electricity consumption. Gulf Pharmaceutical has set a long-term goal to achieve net zero emissions by 2050, targeting both Scope 1 and Scope 2 emissions. This ambitious commitment aligns with industry standards for climate action and demonstrates the company's proactive approach to sustainability. The emissions data is not cascaded from any parent organization, indicating that Gulf Pharmaceutical is independently reporting its performance. The company continues to focus on enhancing its environmental strategies to meet its climate commitments effectively.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
6,300,000
0,000,000
00,000
00,000
Scope 2
29,000,000
00,000,000
00,000
00,000
Scope 3
-
-
00,000
00,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Gulf Pharmaceutical's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Gulf Pharmaceutical is in AE, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Gulf Pharmaceutical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

United Pharmaceutical Establishment

SA
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Jamjoom Pharmaceuticals Factory Company

SA
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Macro Group Pharmaceuticals (Macro Capital) S.A.E

EG
•
Chemicals nec
Updated 13 days ago

Medseven Drugstore LLC

AE
Updated 13 days ago

Aster Dm Healthcare

AE
•
Health and social work services (85)
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy